NeutraHealth announces
asset buys

NeutraHealth subsidiary Brunel Healthcare has acquired the Gerard House and Galloway brands, including seven product licenses, from Potters, the UK subsidiary of pharmaceuticals company Galenica AG, for a combined purchase price of £400,000 cash.


NeutraHealth subsidiary Brunel Healthcare has acquired the Gerard House and Galloway brands, including seven product licenses, from Potters, the UK subsidiary of pharmaceuticals company Galenica AG, for a combined purchase price of £400,000 cash.

NeutraHealth subsidiary Brunel Healthcare has acquired the Gerard House and Galloway brands, including seven product licenses, from Potters, the UK subsidiary of pharmaceuticals company Galenica AG, for a combined purchase price of £400,000 cash.

The Gerard House brand comprises licensed herbal products sold through UK retailers. Galloways’ products, including herbal-based Galloway cough syrup, are sold exclusively through UK pharmacies. In 2007 the brands notched up sales of £270,000.

John Roberts, partner at City firm Goodman Derrick, was adviser to Potters in connection with the sales. Partner John Roberts led the advisory assisted by partner Tanya Shillingford.

Says Roberts: “Galenica AG has been a client of ours for some time and we are delighted to have completed another successful deal for them.”

Marc Barber

Marc Barber

Marc was editor of GrowthBusiness from 2006 to 2010. He specialised in writing about entrepreneurs, private equity and venture capital, mid-market M&A, small caps and high-growth businesses.

Related Topics

Early Stage Funding